| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.094 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |